Clinical Trial Update: Safety and Tolerability Trial of Switching From Ropinirole to Rotigotine [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety and tolerability of switching Parkinson's patients from ropinirole to rotigotine; results were posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Ropinirole (ropinirole)
• Rotigotine (rotigotine)

Snippet

Sponsor: UCB Pharma | Conditions: Parkinson's Disease | Phase 3 | Status: COMPLETED | Results posted: 2009-05-27